四川合信药业有限责任公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
22
NMPA:22
Drug Approvals
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20258024
- Approval Date
- Mar 5, 2025
NMPA
Cefpodoxime Proxetil Tablets
- Product Name
- 头孢泊肟酯片
- Approval Number
- 国药准字H20163274
- Approval Date
- May 10, 2021
NMPA
Cefpodoxime Proxetil for Suspension
- Product Name
- 头孢泊肟酯干混悬剂
- Approval Number
- 国药准字H20163272
- Approval Date
- May 10, 2021
NMPA
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20058742
- Approval Date
- Dec 14, 2020
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20057374
- Approval Date
- Dec 14, 2020
NMPA
Cefminox Sodium for Injection
- Product Name
- 注射用头孢米诺钠
- Approval Number
- 国药准字H20066547
- Approval Date
- Dec 14, 2020
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20057372
- Approval Date
- Dec 14, 2020
NMPA
Cefminox Sodium for Injection
- Product Name
- 注射用头孢米诺钠
- Approval Number
- 国药准字H20067395
- Approval Date
- Dec 14, 2020
NMPA
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20058743
- Approval Date
- Dec 14, 2020
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found